China SXT Pharmaceuticals
SXTC
SXTC
2 hedge funds and large institutions have $32.3K invested in China SXT Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
2
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$11K | |
| 2 | -$7.02K | |
| 3 | -$6.82K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.1K |